The groundbreaking success of Sildenafil undeniably reshaped the drug landscape, but betting in companies strongly reliant on unbranded versions presents a challenging picture. Despite early profits were significant, the end of patents and the emergence of cheaper alternatives have eroded market share. Therefore, a thorough assessment of current… Read More